Literature DB >> 21491182

Effect of grewia gum as a suspending agent on ibuprofen pediatric formulation.

Ikoni Joshua Ogaji1, Stephen W Hoag.   

Abstract

The purpose of this work was to evaluate the potential of grewia gum (GG) as a suspending agent in pharmaceutical oral formulation using ibuprofen as model drug. Ibuprofen pediatric suspension (25 mg/5 mL) was formulated with grewia gum (0.5% w/v) as the suspending agent. Similar suspensions of Ibuprofen containing either sodium carboxymethylcellulose (Na-CMC) or hydroxymethylpropylcellulose (HPMC) were also produced. The suspensions were evaluated for ease of redispersion, sedimentation, rheological properties, and the effect of aging on the rheological properties at 25°C. The particle size and particle size distributions of the dispersed solute were determined. The redispersion time was 19, 11, and 0.5 min, respectively, for formulation containing Na-CMC, HPMC, and GG .The sedimentation volumes were 0.05, 0.05, and 0.125 mL, respectively, for Na-CMC, HPMC, and GG . Viscosities of suspensions at spindle speed of 25 rpm were of the order: GG > HPMC > Na-CMC when freshly prepared and of the order: HPMC > GG > Na-CMC within 6 months of storage. The particles size was 72.72, 73.82, 81.93, and 83.41 μm, respectively, for suspensions containing Na-CMC, ibuprofen alone, HPMC, and GG. Greatest hysteresis was observed in formulation containing HPMC. All the formulations were stable. It was our conclusion that the difference in the physicochemical properties of ibuprofen pediatric formulations was influenced more by the suspending agent used in the formulations than the drug. GG combined better redispersion with minimal changes in viscosity on storage compared to Na-CMC and HPMC as suspending agent. Thus GG may serve as a good suspending agent requiring no further aid in suspension redispersibility.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21491182      PMCID: PMC3134643          DOI: 10.1208/s12249-011-9606-1

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  13 in total

1.  Medicines for children: a matter of taste.

Authors:  Elin Haf Davies; Catherine Tuleu
Journal:  J Pediatr       Date:  2008-11       Impact factor: 4.406

2.  Particle size determination of a flocculated suspension using a light-scattering particle size analyzer.

Authors:  A Bommireddi; L C Li; D Stephens; D Robinson; E Ginsburg
Journal:  Drug Dev Ind Pharm       Date:  1998-11       Impact factor: 3.225

3.  The effect of some biphenyl solubilizing and suspending agents on biphenyl 4-hydroxylase of rabbit liver microsomes.

Authors:  G E Hook; J R Bend; J R Fouts
Journal:  Chem Biol Interact       Date:  1973-10       Impact factor: 5.192

4.  Development of suspending agent from sodium carboxymethyl mungbean starches.

Authors:  O S Kittipongpatana; J Sirithunyalug
Journal:  Drug Dev Ind Pharm       Date:  2006-08       Impact factor: 3.225

5.  [Formulation and stability of suspensions for preclinical study].

Authors:  S Burgalassi; G Perini; B Giannaccini; M F Saettone; A Lodi
Journal:  Boll Chim Farm       Date:  1997-11

6.  Evaluation of Mimosa pudica seed mucilage as sustained-release excipient.

Authors:  Kuldeep Singh; Ashok Kumar; Naresh Langyan; Munish Ahuja
Journal:  AAPS PharmSciTech       Date:  2009-09-18       Impact factor: 3.246

7.  Formulation development and stability studies of aqueous metronidazole benzoate suspensions containing various suspending agents.

Authors:  Sharon Zietsman; Gareth Kilian; Matthew Worthington; Chris Stubbs
Journal:  Drug Dev Ind Pharm       Date:  2007-02       Impact factor: 3.225

8.  Preliminary evaluation of shilajit as a suspending agent in antacid suspensions.

Authors:  M Shahjahan; I Islam
Journal:  Drug Dev Ind Pharm       Date:  1998-11       Impact factor: 3.225

Review 9.  Optimizing oral medications for children.

Authors:  Julie A Mennella; Gary K Beauchamp
Journal:  Clin Ther       Date:  2008-11       Impact factor: 3.393

10.  Evaluation of Spinacia oleracea L. leaves mucilage as an innovative suspending agent.

Authors:  Amit Kumar Nayak; Dilipkumar Pal; Dipti Ranjan Pany; Biswaranjan Mohanty
Journal:  J Adv Pharm Technol Res       Date:  2010-07
View more
  5 in total

1.  Novel extraction and application of okra gum as a film coating agent using theophylline as a model drug.

Authors:  Ikoni J Ogaji; Stephen W Hoag
Journal:  J Adv Pharm Technol Res       Date:  2014-04

2.  Controlled Electrostatic Self-Assembly of Ibuprofen-Cationic Dextran Nanoconjugates Prepared by low Energy Green Process - a Novel Delivery Tool for Poorly Soluble Drugs.

Authors:  Amos Olusegun Abioye; Adeola Kola-Mustapha
Journal:  Pharm Res       Date:  2014-12-20       Impact factor: 4.200

3.  Physicochemical Characterization of Grewia ferruginea Hochst. ex A. Rich Mucilage for Potential Use as a Pharmaceutical Excipient.

Authors:  Tsadkan Gebremeskel Haile; Gereziher Gebremedhin Sibhat; Fantahun Molla
Journal:  Biomed Res Int       Date:  2020-06-07       Impact factor: 3.411

4.  Grewia gum as a potential aqueous film coating agent. I: Some physicochemical characteristics of fractions of grewia gum.

Authors:  Ikoni J Ogaji; Ignatius S Okafor; Stephen W Hoag
Journal:  J Pharm Bioallied Sci       Date:  2013-01

5.  Evaluation of Grewia ferruginea Hochst ex A. Rich Mucilage as Suspending Agent in Metronidazole Benzoate Suspension.

Authors:  Tsadkan Gebremeskel Haile; Gereziher Gebremedhin Sibhat; Ebisa Tadese; Desta Tesfay; Fantahun Molla
Journal:  Biomed Res Int       Date:  2020-10-29       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.